Solesence, Inc. Common Stock
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Kevin Cureton
- Full Time Employees
- 98
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Address
- 1319 Marquette Drive Romeoville IL United States of America 60446
- IPO Date
- Apr 8, 2025
- CIK
- 0000883107
- Website
- solesence.com
- Similar Companies
- Business
- Solesence, Inc. develops, manufactures, and sells mineral-based skin health solutions and engineered materials for the beauty and life science industries. The company provides proprietary Active Stress Defense technology platform, including Original Active Stress Defense and award-winning Kleair; skin care formulations with non-nano mineral UV protection as active pharmaceutical ingredients; sunscreens and daily skin care products; complexion and color cosmetics; white label, white label+, and full custom development services; surface-engineered zinc oxide and titanium dioxide; and advanced materials such as architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, and medical diagnostics applications. Solesence, Inc. operates primarily in the United States from its headquarters in Romeoville, Illinois, where it was incorporated in 1989; it serves global beauty brands across prestige, mass, and EU markets through its wholly owned subsidiary Solesence, LLC. In March 2025, the company changed its name from Nanophase Technologies Corporation to reflect its focus on skin health innovation; it reported record 2024 revenue of $52.3 million, up 40% year-over-year, with expanded production capacity at its Bolingbrook facility to support over $200 million in annual consumer products revenue; launched over two dozen new SKUs; initiated a NASDAQ uplisting process; appointed a dedicated Chief Financial Officer; and earned awards including the 2025 Cosmetics & Toiletries Allē Award for Au Lait Face Milk SPF 50+ featuring Kleair technology.
Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition
Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition
SLSN Incurs Q1 Loss Due to Shipment Delays, High Operating Costs
Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition
Solesence, Inc. (SLSN) Q1 2026 Earnings Call Transcript
Solésence Reports First Quarter 2026 Financial Results
Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™
Solésence To Report First Quarter 2026 Financial Results and Host a Conference Call on May 12
Solésence, Inc. Announces Appointment of New Independent Director
Zacks Initiates Coverage of SLSN With Underperform Recommendation
Solesence, Inc. (SLSN) Q4 2025 Earnings Call Transcript
Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results
Solésence To Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 31, 2026
Reviewing Solesence (NASDAQ:SLSN) and Rejuvel Bio-Sciences (OTCMKTS:NUUU)
Yoolie Park joins Solésence, Inc. as Vice President of Brand Partnerships
Solesence (NASDAQ:SLSN) Stock Price Up 2% – Time to Buy?
Solesence, Inc. (SLSN) Q3 2025 Earnings Call Transcript
Solésence Reports Third Quarter 2025 Financial Results
Solésence, Inc. Appoints Yoana Dvorzsak as Vice President of Innovation and Product Integrity
Solésence To Report Third Quarter 2025 Financial Results and Host a Conference Call